miR‐203a‐3p in CAFs inhibits their phenotypic transition into inflammatory CAFs via the MyD88/NF‐κB/IL‐6 axis, subsequently reducing IL‐6 secretion and suppressing tumour progression. This evidence concerns the gene IL6 and neoplasm.